SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001140361-24-020836
Filing Date
2024-04-19
Accepted
2024-04-19 17:28:53
Documents
19
Period of Report
2024-06-11

Document Format Files

Seq Description Document Type Size
1 PRE 14A ny20024296x1_pre14a.htm PRE 14A 1079486
2 logo_ocuphire.jpg GRAPHIC 33979
3 ny20024296x1_cgallagher.jpg GRAPHIC 35478
4 ny20024296x1_five.jpg GRAPHIC 7044
5 ny20024296x1_four.jpg GRAPHIC 6942
6 ny20024296x1_gmagrath.jpg GRAPHIC 36563
7 ny20024296x1_jpepose.jpg GRAPHIC 35781
8 ny20024296x1_jsmanuso.jpg GRAPHIC 35113
9 ny20024296x1_one.jpg GRAPHIC 6802
10 ny20024296x1_rrodgers.jpg GRAPHIC 35521
11 ny20024296x1_sainsworth.jpg GRAPHIC 34832
12 ny20024296x1_six.jpg GRAPHIC 7111
13 ny20024296x1_skbenton.jpg GRAPHIC 35974
14 ny20024296x1_three.jpg GRAPHIC 7210
15 ny20024296x1_two.jpg GRAPHIC 7067
16 ny20024296x1_pc01.jpg GRAPHIC 697480
17 ny20024296x1_pc02.jpg GRAPHIC 774656
18 ny20024296x1_pvp01.jpg GRAPHIC 156588
19 ny20024296x1_pvp02.jpg GRAPHIC 164931
  Complete submission text file 0001140361-24-020836.txt   3996155
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-34079 | Film No.: 24859019
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)